This document discusses the diagnosis, management, and treatment of diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS). DKA and HHS are life-threatening hyperglycemic emergencies that differ in severity of dehydration and presence of ketosis/acidosis. Treatment focuses on fluid replacement, electrolyte correction, reversing acid-base imbalance, and normalizing blood glucose while searching for precipitating factors. Successful treatment requires frequent monitoring and achieves stability within 12-36 hours. Preventing recurrences relies on patient education and access to healthcare during illness.
This document discusses the diagnosis, management, and treatment of diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS). DKA and HHS are life-threatening hyperglycemic emergencies that differ in severity of dehydration and presence of ketosis/acidosis. Treatment focuses on fluid replacement, electrolyte correction, reversing acid-base imbalance, and normalizing blood glucose while searching for precipitating factors. Successful treatment requires frequent monitoring and achieves stability within 12-36 hours. Preventing recurrences relies on patient education and access to healthcare during illness.
This document discusses the diagnosis, management, and treatment of diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS). DKA and HHS are life-threatening hyperglycemic emergencies that differ in severity of dehydration and presence of ketosis/acidosis. Treatment focuses on fluid replacement, electrolyte correction, reversing acid-base imbalance, and normalizing blood glucose while searching for precipitating factors. Successful treatment requires frequent monitoring and achieves stability within 12-36 hours. Preventing recurrences relies on patient education and access to healthcare during illness.
This document discusses the diagnosis, management, and treatment of diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS). DKA and HHS are life-threatening hyperglycemic emergencies that differ in severity of dehydration and presence of ketosis/acidosis. Treatment focuses on fluid replacement, electrolyte correction, reversing acid-base imbalance, and normalizing blood glucose while searching for precipitating factors. Successful treatment requires frequent monitoring and achieves stability within 12-36 hours. Preventing recurrences relies on patient education and access to healthcare during illness.
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 13
Diagnosis and management
of hyperglycemic emergencies
Tasya Sylvia Nursofa
4151161511 Introduction • Diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state (HHS) are life-threatening manifestations of decompensated diabetes mellitus. Clinically, they differ by the severity of dehydration and whether or not ketosis Hyperglycemic emergencies 251 and metabolic acidosis are present. Excess secretion of glucagon, catecholamines, cortisol and growth hormone promotes gluconeogenesis, glycogenolysis and lipolysis, resulting in DKA through a relative (type 2 diabetes) or absolute (type 1 diabetes) deficiency of insulin effect. These occur under stress, serious infection, trauma and cardiovascular emergencies. Characterized by severe hyperglycemia, hyperosmolarity and dehydration (but without apparent ketoacidosis), HHS is typically seen in elderly type 2 diabetic patients and carries a higher mortality rate (5-20%) compared to DKA (<2%). Diagnosis • The symptoms of DKA begin rapidly, i.e. within hours of a precipitating event, while HHS develops insidiously over days or weeks. Hyperglycemia- associated symptoms common to both include polyuria, polydipsia, weight loss, increasing malaise, orthostatic dizziness and dry mucous membranes. Kussmaul respirations, acetone-scented breath, nausea, vomiting and abdominal pain (due to ketosis itself and correlating with the severity of acidosis) may occur in DKA. Late symptoms in severe cases of either disorder include confusion or stupor, which can progress to mental obtundation and coma. Precipitating Factors • The most common illnesses precipitating DKA or HHS are infections, including viral syndromes, urinary tract infections, pelvic inflammatory disease, pneumonia, mucormycosis, malignant otitis externa (with pseudomonas aeruginosa), periodontal abscess and dental infection. Fever is frequently absent even with active infection; conversely, leukocytosis (≥20,000/mm3 ) and even leukemoid reactions may be present in the absence of infection. The possibility of meningitis should be considered in patients with nuchal rigidity, photophobia and headache or when a depressed level of consciousness does not improve promptly with hydration and blood sugar reduction. Precipitating Factors • Drugs affecting carbohydrate metabolism (e.g. corticosteroids, second generation antipsychotic agents) can precipitate either emergency. Cocaine abuse causes recurrent DKA via several mechanisms, including therapeutic noncompliance, stimulation of adrenal release of epinephrine and norepinephrine and increased release of other counter regulatory hormones. Differential Diagnosis • Other causes of metabolic acidosis and ketosis must be differentiated from DKA. Acute renal failure accounts for ~5-7% of all adult hospitalizations.30,31 It shares the common feature of an elevated anion gap metabolic acidosis, but can be easily differentiated from DKA by the absence of hyperglycemia or ketonemia. Conversely, severe cases of DKA or HHS can lead to prerenal azotemia and secondary acute kidney injury. Uremia typically develops when creatinine clearance falls to and ethylene glycol will also cause a serum osmolal gap. • Measuring suspected drug/toxin concentrations when the index of suspicion is high can confirm the diagnosis of acute intoxication. Non-anion gap metabolic acidosis is characterized by a low serum bicarbonate concentration (via gastrointestinal or renal losses) with subsequent chloride retention. Diarrhea and renal tubular acidosis are frequent causes of this condition, which can also occur with carbonic anhydrase inhibitor therapy. Rapid dilution of plasma bicarbonate by infused saline can result in a non-anion gap metabolic acidosis as well. Diabetic ketoacidosis can be easily differentiated from this condition by the presence of an increased anion gap and hyperglycemia. Treatment • Treatment Treatment of both DKA and HHS focuses on replacing volume deficits, correcting electrolytes, reversing the acid-base imbalance, normalizing blood glucose and treating precipitating factors to prevent recurrence and hasten recovery. Successful treatment of either condition requires frequent monitoring of clinical and laboratory parameters. A flow sheet recording laboratory results, vital signs and fluid balance is helpful in monitoring progress and adjusting therapy. A systematic approach to treatment should achieve clinical stability within 12-36 hours. A sample protocol for managing adult patients with hyperglycemic emergencies is summarized in Figure 1. Additionally, endocrinology/diabetes team consultations may result in shorter hospital stays, fewer medical procedures and lower medical costs and should be considered for most patients Monitoring • General recommendations for ongoing laboratory monitoring include hourly blood glucose levels for the first 4-6 hours, and at 2 hour intervals subsequently; electrolyte and CO2 content (every 2- 4 hours) and blood urea nitrogen and creatinine levels (every 4 hours) should also be monitored until stable. Fluid intake and output should be accurately recorded.3 Since serum bicarbonate and anion gap are good indices of therapeutic response, repeated assessments of arterial blood gases or serum or urine ketones are usually unnecessary. As β-hydroxybutyrate converts to acetoacetate, and conventional (nitroprusside) testing detects only acetoacetate and acetone, standard ketone levels during therapy may appear unchanged or erroneously high even when treatment has successfully arrested ketogenesis.32 When acidosis begins to resolve, the anion gap falls to near normal and the response to glycemic therapy becomes predictable, it is reasonable to reduce laboratory test frequency.32 Persistent acidosis that does not respond to treatment may be caused by sepsis, concomitant illness or inadequate insulin dosing and mandates further evaluation and intervention.3,32 Complications of Therapy • Hypoglycemia and hypokalemia are the two most common complications seen during treatment of DKA. • Cerebral edema occurs in 0.3-1% of children with DKA but is very rare in adults7,77 and its mechanism is debated. • 7,77-83 Other reported life-threatening complications include adult respiratory distress syndrome, hydrostatic pulmonary edema, bronchial mucous plugging, ischemic intestinal necrosis and arterial and venous thromboses; 32,84-88 standard low-dose unfractionated heparin or low molecular weight heparin prophylaxis is reasonable adjunctive therapy when no contra-indications are present.32,87 Prevention of recurrences • Hyperglycemic emergencies are usually preventable. Infection and medical noncompliance are the two most common causes of DKA and HHS. Established patients should be educated on how to manage their diabetes during stress or infection; this “sick-day management” includes never omitting insulin, preventing dehydration and hypoglycemia, monitoring blood glucose frequently, testing for ketosis, administering supplemental rapid- acting insulin doses according to prescribed guidelines, treating underlying triggers early and aggressively and having frequent contact with their diabetes health care team to evaluate their acute condition.32,89 Patient education and 24-hour access to care are cornerstones of preventive therapy. Educating caregivers to recognize signs and symptoms of worsening hyperglycemia and dehydration can reduce the incidence and severity of HHS. For patients who live alone, family or friends should check daily to assess for changes in mental status or signs of dehydration. Summary • Though the hyperglycemic emergencies DKA and HHS are life-threatening, with mortality rates up to 20% (for HHS), they are largely preventable conditions. A diligent search for precipitating causes contributes to better outcomes and fewer recurrences, while an organized, methodical and aggressive approach to treatment can achieve clinical stability in 12- 36 hours. Patient education and easy access to health care resources are essential to prevent recurrences. No conflict of interest or financial support declared.